CB vs CGEM · P/E 14, rev $59.40B vs $830.3M cap
Chubb Ltd (CB) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the CB and CGEM stock pages for the full models.
Not investment advice.